NCT00180089View on ClinicalTrials.gov

Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation

PHASE3CompletedINTERVENTIONAL

Enrollment

242

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

January 31, 2010

Conditions

LeukemiaGraft-Versus-Host Disease

Interventions

DRUG

Budesonide

Trial Locations (1)

01307

Medical Department I, Technical University Hospital, Dresden

Sponsors

Collaborators (1)

Dr. Falk Pharma GmbH

All Listed Sponsors

collaborator

Dr. Falk Pharma GmbH

INDUSTRY

lead

Technische Universität Dresden

OTHER